Daniel J. Starks, Director at ABBOTT LABORATORIES (ABT), bought 9,212 shares at $60.73 ($559K) on 2018-02-27, disclosed to the SEC on 2018-02-28.
Open-market purchase of $559k ABT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.62 | 1,417 | $86K | 15.4% |
| 2 | $60.65 | 1,500 | $91K | 16.3% |
| 3 | $60.67 | 2,799 | $170K | 30.4% |
| 4 | $60.72 | 1,317 | $80K | 14.3% |
| 5 | $60.73 | 1,079 | $66K | 11.7% |
| 6 | $60.75 | 1,100 |
| $67K |
| 12.0% |
| Total | $60.68 avg | 9,212 | $559K | 100% |
| Filing → |
| ABT | SELL | 2023-10-30 | $9.4M | — | Filing → |
| ABT | SELL | 2023-07-28 | $11.4M | — | Filing → |
| ABT | SELL | 2023-05-02 | $10.7M | — | Filing → |